v3.26.1
Segment Information - Additional Information (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Segment Reporting [Abstract]          
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description     The Company’s CODM, its Chief Executive Officer, views the Company’s operations and manages the business as one operating segment focused on the development and commercialization of gene therapies to treat an array of diseases.    
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]     srt:ChiefExecutiveOfficerMember    
Cash, cash equivalents and marketable securities $ 105.5   $ 105.5   $ 240.9
Interest income from investments $ 1.2 $ 3.4 $ 3.2 $ 5.9